ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000592.1|Microviridin_2 # 1608 # 2888 # 1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.439	BGC0000592.1|Microviridin_2 	1608	2888	+	Loose	1650	26.1794	Brucella suis mprF	42.0	3003772	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	defensin resistant mprF	ATGGTGAGAAGACAGTCCCTTATTAGTAGGAAACTAAGCGGTTTTAGTGAGCAGTTTAGCTTCATTTTCCGGGATATAGCCCAAATGGATCGGCTTTTGTTCGTTTTGGTGACGGGTTTAACCGTTTTCGGTGGTTTAATGATTCGTAGTGCCGAAAGACATACCACTGCTCTCGATTGGTGGCAACACTGGTTATTCGGATGCGTGGGAGTGGCGATCGCTTTATTTCTGGCCCGTTGTCGTTACGAAAGTCTGCTGAAATGGCACTGGTTAACCTATCTTCTCACCAATCTCTCCCTAATCGCGGTAATTATCCTAGGCGTGACGGCGAATGGGGCGCAAAGTTGGATTAATATCGGCAGTTTTAACGTGCAACCGTCGGAATTTGCCAAGGTAGGTTTAATTATCACCCTAGCAGCCCTCCTACATCATCGTCCCGCCGATAATCTTTTTGCGATCGCTCGTGTCTTTGCCGTCACTGCCATCCCCTGGGTGTTAATTATGGCGCAGCCGGACCTGGGGACAGGATTAGTCTTTGGGGCAATTACCCTAGGCATGATTTACTGGGCTAATGCGAAACTGCCTTGGATGATTATCCTGTTATCTCCCATCGCATCGGTTTTTCTGTTTAATTTACTTTTTCCTGCTTGGATTGTTTTAGCAATTATCATCGCTGTGCTTGCTTGGTTTACCCTTCCCTACCGTTTTTTATCTACTTTCATCGTGGTGGCAACTAATCTGGCAGTGGGTAAATTAGGCGAGGTTTTTTGGGGTTTATTAAAAGAATATCAAAAAGATCGTTTAACCCTATTTCTTCACCCAGAAAAGAATCCTTTGGGGGGAGGTTATCAATTAATTCAATCCCGCATTGCCATCGGATCAGGAGAATTATTGGGACGGGGATTACACCAAGGCACCCAAACCCAATTAAATTTTATTCCCGAACAACACACCGATTTTATCTTCTCGGTAGTCGGGGAAGAACTCGGTTTTGTTGGCAGTATTCTAGTTTTAATAGCTTTCTGGTTAGTTTGTTGGCGTTTGTTAGTCATTGCTAATACTGCTAAAGAAAACTTCGGTTCTTTAATAGCGATCGGTGTTCTCTCGATGATCGCTTTTCAGGCAATTCTTAATATTAGCATGACCGTGGGATTAGCCCCGATTACAGGGATTCCTTTACCTTGGTTAAGTTATGGACGTTCATCTTTATTAACCAATTTTATCGCCTTGGGTTTAGTGGAATCCGTGGCTAATTATCGCCCCCGTAAGCGTTTATACTAA	MVRRQSLISRKLSGFSEQFSFIFRDIAQMDRLLFVLVTGLTVFGGLMIRSAERHTTALDWWQHWLFGCVGVAIALFLARCRYESLLKWHWLTYLLTNLSLIAVIILGVTANGAQSWINIGSFNVQPSEFAKVGLIITLAALLHHRPADNLFAIARVFAVTAIPWVLIMAQPDLGTGLVFGAITLGMIYWANAKLPWMIILLSPIASVFLFNLLFPAWIVLAIIIAVLAWFTLPYRFLSTFIVVATNLAVGKLGEVFWGLLKEYQKDRLTLFLHPEKNPLGGGYQLIQSRIAIGSGELLGRGLHQGTQTQLNFIPEQHTDFIFSVVGEELGFVGSILVLIAFWLVCWRLLVIANTAKENFGSLIAIGVLSMIAFQAILNISMTVGLAPITGIPLPWLSYGRSSLLTNFIALGLVESVANYRPRKRLY	MLWWDDISMSLIDDEIPSSQPQVSGRHFGWLKQYQHFLFPIAGIAIALLAIYVLENLLRHTSRTETLAALHNISWTTLALAVFFTALSYAAVALYDVVAVDTIAPNQIPRRIAAVAGAAGYAISNALGFSLLTGGALRYRIYAAEGISLADIGKIVGTSWFAIWFALIIMVGAALLIDPQDVPFLSAIDIRIDIVAGILILGGIGWLIYWLSHGERNVSIGSFSLRLPNSKGALTQIFAGVVDVGAAAATLYVLLPEGAVPSFAVFALVYVIAIVLGIASHAPGGLGAFEATIIAGLGLGGKPDAIAGLLAYRLIYTVLPLVVATAGILIWEVMRRRHMLDKQARFAKRLVEPLVPGLSASIIFLGGIILLISGATPDMRYRVKLLSDIVPEFLVEMSHLAASLVGVALLIVARGLSKRLERAWVAAMVLLLCGAVFSIAKGLDWEEASILCLFALSLWGFRDSFYRRPIAGPFELSWNWIATVGTTVLVSTWLGFFVYRHIEYSSDLWWDFAWNGNAPRFLRATVLVFAVVAAVGLHSIINRHGQRRRKVDHSIPDAVPALVARCPHTDAALAMLGDKQFLLAPDDSAFIMYAQSGGSLIALGEPIGDAEAGKELAWSFHSLADRLALRTVFYGVGPQSLPLFLDMGLIALKLGEVARVDLTDFSLEGPRRQPFRYADRKVDKDGLTFEIIPAADVPPLIPRLRAISDAWLDHKSGSEKGFSLGYFNDEYLKRFDIAVLKKDGEIVAFANIWRGADKYEITVDLMRYMPNVHKLLMDALFAKLLTFSKQEGYKWFNLGAAPLSGLSGSRLASRWNRFGSFIYRRGADLYHFDGLKAFKEKFDPVWTPHYMVCPGGLETPRALLDATTLINGSPLEFIRK	48.41	gnl|BL_ORD_ID|2057|hsp_num:0	2281			75	222	defensin
BGC0000592.1|Microviridin_3 # 3422 # 3574 # 1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.458	BGC0000592.1|Microviridin_3 	3422	3574	+	Loose	600	21.557	AER-1	35.29	3002481	protein homolog model	n/a	n/a	penam	antibiotic inactivation	AER beta-lactamase	ATGGCATATCCCAACGATCAACAAGGTAAAGCACTTCCTTTCTTTGCTCGTTTCTTGTCCGTAAGCAAAGAGGAATCTTCCATCAAGTCTCCTTCCCCTGAGCCTACCTTCGGGACCACCTTGAAATACCCTTCTGACTGGGAAGAGTATTAA	MAYPNDQQGKALPFFARFLSVSKEESSIKSPSPEPTFGTTLKYPSDWEEY	MYVLSVEKPTLRNKFAAGIGVVLVCVVASFIPTPVFALDTTKLIQAVQSEESALHARVGMTVFDSNTGTTWNYRGDERFPLNSTHKTFSCAALLAKVDGKSLSLGQSVSISKEMLVTYSPITEKSLSPETVTFGKICQAAVSYSDNTAANVVFDAIGGATGFNAYMRSIGDEETQLDRKEPELNEGTPGDVRDTTTPNAMVNSLRKILLGDALSASSRSQLTQWMLDDQVAGALLRASLPSDWKIADKTGAGGYGSRSIVAVIWPPSKQPLVVGIYITQTKASMQASNQAIARIGVVLKDTVAP	16.45	gnl|BL_ORD_ID|1061|hsp_num:0	1149			459	561	
BGC0000592.1|Microviridin_4 # 3850 # 4827 # 1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=AGGA/GGAG/GAGG;rbs_spacer=11-12bp;gc_cont=0.409	BGC0000592.1|Microviridin_4 	3850	4827	+	Loose	200	25.7942	FosX	36.67	3000198	protein homolog model	n/a	n/a	phosphonic acid antibiotic	antibiotic inactivation	fosfomycin thiol transferase	ATGAAAGAATCGCCTAAAGTTGTTTTATTGTTGACCCATAGCGGCGATTTTTTCACGATTGACCGCGTGGCTGAGGCGATAGAAAAAAAAGGAGCCACACCTTTTCGCTTAGATACCGATAAATTTCCCTTAGAGGTTCAATTAGCAGCCCAATTTAATGGGAAAAAAAGTTTTTATCAATTAACCTATAACCATCAATCTATTGATAGTGAACAGGTGCAATCTGTTTGGACAAGACGTATTTGGCAACCTGAAATAACAGGAGATTTAGATCCTCAGTTTCGGGAGGCTTGTGTGCGAGAATCCCAGACGACTTTGGCTGGTTTTTGGGATAGTTTAAGGTCAGCGCGTTGGTTAGATAATTTAGCGCAAATTGAGAGGGCTAAAAATAAGTTATTACAACTTCGTTTGGCCTCAGAAGTTGGCTTGATTATCCCCCCCACTTTAGTGACCAATAATCCTGATGCTGCCCGGGAGTTTTTTTCCCAGGTTCAGGGAAGAATGGTGAGTAAATTGTTAACTGCGATCGCCCGAAGTATGGAGTCGCCGGAATTTTTTCTTTATACCAGTAGGGTGAAAGCAGAAGACCTTGAGGAAGCGGAATCTTTACGTTATTGTCCCATGGTTTTTCAAGCGGAAATTCCCAAACAATTAGAATTGAGAGTTGTCGTGGTTAATGGACAGACATTTGTGGGAGCTTTAGAATCTTCTCAGTATAATAATTCTGCCGTAGATTGGCGAAGACCGNGTATTGATCCTGGTGCTTGGCAACATCATACTTTACCCGATTCACTATTGCAGCAACTTCAGATTTTTATGGCTAATTTAGGGTTGAATTTTGGGGCGTTTGATTTTATCTTAACTCCTGGGGGAGAATACGTTTTTTTAGAAGTTAATCCGGGTGGTGAGTGGGGAATGTTAGAACGGGATTTAGATTTACCTATTTCTAATGCGATCGCTGATTTTTTAGTATGCTAA	MKESPKVVLLLTHSGDFFTIDRVAEAIEKKGATPFRLDTDKFPLEVQLAAQFNGKKSFYQLTYNHQSIDSEQVQSVWTRRIWQPEITGDLDPQFREACVRESQTTLAGFWDSLRSARWLDNLAQIERAKNKLLQLRLASEVGLIIPPTLVTNNPDAAREFFSQVQGRMVSKLLTAIARSMESPEFFLYTSRVKAEDLEEAESLRYCPMVFQAEIPKQLELRVVVVNGQTFVGALESSQYNNSAVDWRRPXIDPGAWQHHTLPDSLLQQLQIFMANLGLNFGAFDFILTPGGEYVFLEVNPGGEWGMLERDLDLPISNAIADFLVC	MISGLSHITLIVKDLNKTTAFLQNIFNAEEIYSSGDKTFSLSKEKFFLIAGLWICIMEGDSLQERTYNHIAFQIQSEEVDEYTERIKALGVEMKPERPRVQGEGRSIYFYDFDNHLFELHAGTLEERLKRYHE	244.36	gnl|BL_ORD_ID|111|hsp_num:0	129			81	258	fosfomycin
BGC0000592.1|Microviridin_5 # 4933 # 5133 # 1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.328	BGC0000592.1|Microviridin_5 	4933	5133	+	Loose	470	26.1794	gadW	32.26	3003838	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; penam	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGACCGTTTTAATTGTTACTTTTAGCCATGATAATGAAAGTATTCCTCTGGTAATCAAAGCCATAGAAACGATGGGTAAAAAAGCCTTCCGTTTTGTTGAGGATTTTAGGATTATCAAGATTCTCAATCCAAAATCTAATCAGGATTCTCAATCCCAAATCATCAAGGAAATCTATGACCGTTTTAATTGTTACTTTTAG	MTVLIVTFSHDNESIPLVIKAIETMGKKAFRFVEDFRIIKILNPKSNQDSQSQIIKEIYDRFNCYF	MAHVCSVILVRRSFDIHHEQQKISLHNESILLLDKNLADDFAFCSLDTRRLDIEELTVCHYLQNIRQLPRNLGLHSKDRLLINQSPPIQLVTAIFDSFNDPRVNSPILSKMLYLSCLSMFSHKKELIPLLFNSISTVSGKVERLISFDIAKRWYLRDIAERMYTSESLIKKKLQDENTCFSKILLASRMSMARRLLELRQIPLHTIAEKCGYSSTSYFINTFRQYYGVTPHQFSQHSPGTFS	27.27	gnl|BL_ORD_ID|2082|hsp_num:0	2324			357	540	erythromycin; cloxacillin; oxacillin; norfloxacin
BGC0000592.1|Microviridin_6 # 5108 # 5308 # 1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.328	BGC0000592.1|Microviridin_6 	5108	5308	+	Loose	470	26.1794	gadW	32.26	3003838	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; penam	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGACCGTTTTAATTGTTACTTTTAGCCATGATAATGAAAGTATTCCTCTGGTAATCAAAGCCATAGAAACGATGGGTAAAAAAGCCTTCCGTTTTGTTGAGGATTTTAGGATTATCAAGATTCTCAATCCAAAATCTAATCAGGATTCTCAATCCCAAATCATCAAGGAAATCTATGACCGTTTTAATTGTTACTTTTAG	MTVLIVTFSHDNESIPLVIKAIETMGKKAFRFVEDFRIIKILNPKSNQDSQSQIIKEIYDRFNCYF	MAHVCSVILVRRSFDIHHEQQKISLHNESILLLDKNLADDFAFCSLDTRRLDIEELTVCHYLQNIRQLPRNLGLHSKDRLLINQSPPIQLVTAIFDSFNDPRVNSPILSKMLYLSCLSMFSHKKELIPLLFNSISTVSGKVERLISFDIAKRWYLRDIAERMYTSESLIKKKLQDENTCFSKILLASRMSMARRLLELRQIPLHTIAEKCGYSSTSYFINTFRQYYGVTPHQFSQHSPGTFS	27.27	gnl|BL_ORD_ID|2082|hsp_num:0	2324			357	540	erythromycin; cloxacillin; oxacillin; norfloxacin
BGC0000592.1|Microviridin_7 # 5283 # 6257 # 1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.391	BGC0000592.1|Microviridin_7 	5283	6257	+	Loose	350	37.3502	vanP	23.0	3007189	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; Van ligase	ATGACCGTTTTAATTGTTACTTTTAGCCACGATAATGAAAGTATTCCTCTGGTAATCAAAGCCATAGAAACGATGGGGAAAAAAGCCTTCCGTTTTGATACCGATCGCTTCCCTACAGAGGTGAAAGTTGATCTTTACTCAGGCGGTCAAAAAGGCGGAATTATTACCGATGGAGACCAAAAATTAGAGCTAAAAGAAGTTTCTGCTGTCTGGTATCGACGCATGAGATACGGACTAAAATTACCCGATGGGATGGATAGTCAATTTCGCGAAGCTTCTCTTAAGGAATGTCGGTTAAGTATTCGAGGAATGATTGCTAGTTTATCTGGCTTTCATCTTGATCCAATTGCTAAGGTAGATCATGCCAATCATAAACAATTGCAGTTACAAGTAGCGCAACAATTAGGTTTATTAATTCCGGGGACTTTAACTTCTAATAATCCTGAAGCTGTCAAGCAATTTGCTCAGGAGTTTGAAGCAACGGGAATTGTGACTAAAATGCTTTCTCAATTTGCTATTTATGGAGACAAGCAAGAGGAAATGGTTGTTTTTACCAGTCCTGTTACAAAGGAAGACCTAGATAATTTGGAAGGTTTGCAATTTTGTCCCATGACTTTTCAGGAAAACATTCCTAAAGCTTTGGAATTACGCATCACTATTGTCGGTGAACAAATATTTACGGCGGCGATTAATTCCCAACAATTAGACGGTGCTATCTACGATTGGCGAAAAGAGGGAAGAGCGCTCCATCAACAATGGCAACCCTACGATTTACCGAAAACTATTGAAAAACAACTACTAGAATTAGTGAAATATTTCGGTCTCAATTATGGTGCAATTGATATGATTGTCACACCAGATGAACGTTATATCTTTTTAGAAATTAATCCCGTTGGCGAGTTTTTCTGGCTAGAACTTTATCCTCCTTATTTTCCTATCTCCCAGGCGATCGCTGAAGTCCTCGTCAACTCATAA	MTVLIVTFSHDNESIPLVIKAIETMGKKAFRFDTDRFPTEVKVDLYSGGQKGGIITDGDQKLELKEVSAVWYRRMRYGLKLPDGMDSQFREASLKECRLSIRGMIASLSGFHLDPIAKVDHANHKQLQLQVAQQLGLLIPGTLTSNNPEAVKQFAQEFEATGIVTKMLSQFAIYGDKQEEMVVFTSPVTKEDLDNLEGLQFCPMTFQENIPKALELRITIVGEQIFTAAINSQQLDGAIYDWRKEGRALHQQWQPYDLPKTIEKQLLELVKYFGLNYGAIDMIVTPDERYIFLEINPVGEFFWLELYPPYFPISQAIAEVLVNS	MRKVLVLFGGCSEEHDISVKSATEVYHYIDKQKYDVTYVGITKDGRWRKVNSPKEPLEESKTMAILSPDTGKKGILLIEENTYTLQEIDVIFPVMHGKMGEDGQLQGIMELSGIPYVGCDIESSVIAMDKSLANMVADRAGILVPWFMAKNDVKEFDADILPYPVFVKPARSGSSFGISKVENREQFADAVKEALQYDSKILVEEAIQGQEVACAIMGRGEELLTGEVDMVQVKNGFFRIHQEKNPEGGSENAVITVPAPLDMPATERIKKEAKKIYKALGCKGLARVDMFLTKEGRIVLNEVNTLPGMTCYSRYPAMMKAAGIEFTDMVERLIEEALGANA	94.74	gnl|BL_ORD_ID|4819|hsp_num:0	5805			378	948	vancomycin; teicoplanin
BGC0000592.1|Microviridin_8 # 6460 # 6993 # -1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.412	BGC0000592.1|Microviridin_8 	6460	6993	-	Loose	300	32.7278	AAC(2')-IIa	34.43	3004628	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(2')	ATGAAAGCACTGGAAAAACTGGTGACGGAACGATTATATTTAGTCCCCTTAAAGCTTGAACTTCTCAAGGCCGCAATTATAGGTATCGATGAATTAGCAACAATTTTGGGGGTAAAAGTTGCCGATGACTGGGCCGAACAAGAATTGATTCAAGCTTTCCCTGATATTGCGAATATTTTGCTGCAATTCCCCTTACAAAATGAATGGGGATGGGGGAGTTTAATTATTCATCAAGCAGAAAATACTCTTATTGGTCATGTGATGATCAAAATTATTCCTGATGTCACAGGTTTACCCACAGATGCTGTAGAAATTGGCTATCAAGTAGCACCGTTATATCGACGACAAGGCTACGCATCTGAGGCGACAAAAGCAATGATGGACTGGACACTTTCTCAACCTGGTATGCAAACAGTGACCGCTGGCTGCGCTCCCGATAATATAGCTTCAAAGCGAGTTTTAGAAAAAATAGGCATGGATCTGATAGAAGCGCGAGAGAAAGTCTTGATCTGGAAATTAAGTAGGGTTTGCTGA	MKALEKLVTERLYLVPLKLELLKAAIIGIDELATILGVKVADDWAEQELIQAFPDIANILLQFPLQNEWGWGSLIIHQAENTLIGHVMIKIIPDVTGLPTDAVEIGYQVAPLYRRQGYASEATKAMMDWTLSQPGMQTVTAGCAPDNIASKRVLEKIGMDLIEAREKVLIWKLSRVC	MKDRSHDDSMAEVCRNTSENHWLKTDYRTLFRLCPDGRIERENDPDCSPGPRFWLAGCSEGNVFGVRADVPDDIALKLEELASVEPPFTPPAIPKHLERYLSLLGSDGPVTHDLGLIYELPHAQQYPSKARLIGSGSEEGESLMQSWAEDRVPEALFELGFREVADFWTPWCAAVVDGEVASIAFAARLADAGAELGLVTAKAFRGQGFAAAATAGWSRLSALRSRTLFYSTDRDNISSQRVAARLGLRLRGASLRISRA	68.08	gnl|BL_ORD_ID|2209|hsp_num:0	3327			576	750	kasugamycin
BGC0000592.1|Microviridin_9 # 7147 # 9210 # -1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.367	BGC0000592.1|Microviridin_9 	7147	9210	-	Loose	1000	81.2629	msbA	21.19	3003950	protein homolog model	n/a	n/a	nitroimidazole antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGCCTCAATATACTACTAAACAAGCAACGGAAAACCCTGTTGTGTCCGACCAGTCCGCCAATAATCCCTTTTCACTATTTGGTCAATTTTGGGAAAGCCTAAAAATTGTGGCTCAACCCTATTGGTATCCAACGGAGTTAAATGGACGTGCCTTTGGAGATGTGATCATTTCTTGGGGAATGTCAGCTTTGATCCTTTTAAGTATCTTGGCAACAGTCGGGGTAGAAGCTTTTAGTAGCTACTGGAATCGTTATGTACTCGATATTATTATTGAAGATAGAGATCTTTCTAAATATCTAAATACGCTTTGGTTATCCAGTTTGTTGATTATAGGAACAACGGGGTTATTTGCTTTTTCTCAATTTATTCGTCGTCAAGTGGCATTGGATTGGTATAAGTGGTTAACCAAACAAACCGTTAAAAAATATCTCAATGATCGCGCTTATTATAACATTGATTTTACCTCAGCTTTAAAAAATCCCGATCAAAGATTATCTCAAGAAATTGAACCAATTACGACCATGACCCTAAGGTTGTTAATTACCTTCGTGGAAAAAGGGTTGCAAATGATTACTTTTGCGATTATTCTTTGGACAATTTCTCGGCAAATTGCGGTTTATCTAATAATTTATACAATCGCAGGAAATTTCATAGCAATTTATCTAACTCAAGAATTAAACAAAATTAATCAATCGGAGCTTAATCATAAAGCTGATTATAATTATGCTTTAACCCATGTGCGTAACCACGCCGAATCAATTGCTTTTTTTCAGGGAGAAGAGCAGGAAGAAAAAATCATTGAAGACCGTTTTCAACGGGTTATTCAAAGCTCGGAAAAACTGATCAATTGGGAACGGTTTAATAATCTTTTTAATCGAGGTTATCAGTCAGCGATTAGTGTATTTTCAATGTTTATTTTGACCCCGATGTTTATTAAAAACGAAATCGATTATGGGGAAATTAGTCAAGCGAGTTTATGCTGTTTCCTTTTTTCTAATGCCTTGGGACAATTAATTACTGAATGGGGAACATCGGGTAAAGTTTCAAGTTATATTGAACGGTTAGCTACCTTGACAGATGCCTTAAAAGTTGCCAGTGAAGAGCCGAAAAACTTAAGTCGTATTACCACCCTGGAAGATAATCGTCTAGCTTTTGAAAATTTTACCCTACAAACTCCCGATTATGAAAAGGTAATTGTGGAAAATTTATCGGTTTCTGTCCCTTTGGGAGAAAGCTTACTGATTATTGGCCCCAGTGGTCGAGGAAAAAGTTCCTTGTTACGAGCAATCGCCGGTTTATGGAAAGCAGGTAGTGGTCGTTTAGTTCGTCCTCCTTTAGCTAAAATGTTATTTTTACCCCAACGTCCTTATATTATCCTTGGCACTTTACGCCAGCAATTACTTTATCCCCATACCAATGAGCAGGTGAGCGATGAAGAATTAGAAAACATCTTAAAAAAAGTCAACCTGCAACATTTATTAACTGACAAAAATACCTTGGATAAACAAGTCAATTGGGAACAGATTTTATCCCTCGGAGAACAACAAAGATTAGCTTTTGCTCGACTATTAATCACTAAACCCACTTTTACTATCTTAGATGAAGCAACCAGCGCTTTAGATTTGGCCAATGAAGCCAGCTTATATCAGCAATTACAGGAAAGTGAAACCACCTTTATTAGTGTTGGTCATCGGGAAAGTTTATTTAATTATCATCGATGGGTCTTAGAGTTAACAGAAAATTCCCATTGGCAGCTGTCAACTGTAGAAGATTATCAGCGCAAAAAAGTGAATAACCTAGTGATGATGTCAAAAAAATCAGAAAATTTTTCGTCGGTAAAAATAGAGACTTTGTCTGAGGTTAAAACTGAGCATGATGCGGAAATTGCCGGAGTTTCTGAAATAGCAGAAGGTTTGTCCCATCAACAAATGCAGTCCCTAACTGATTATTCTTTAAGTAACGTCCGGAGTCGTGCCAGTTTAGGTAAAATTATTACTGCCAAAGATGGTTTTAATTATCGTTACGATAAAGACCCAAAAACCTTAAAATGGGTGAGAATATAG	MPQYTTKQATENPVVSDQSANNPFSLFGQFWESLKIVAQPYWYPTELNGRAFGDVIISWGMSALILLSILATVGVEAFSSYWNRYVLDIIIEDRDLSKYLNTLWLSSLLIIGTTGLFAFSQFIRRQVALDWYKWLTKQTVKKYLNDRAYYNIDFTSALKNPDQRLSQEIEPITTMTLRLLITFVEKGLQMITFAIILWTISRQIAVYLIIYTIAGNFIAIYLTQELNKINQSELNHKADYNYALTHVRNHAESIAFFQGEEQEEKIIEDRFQRVIQSSEKLINWERFNNLFNRGYQSAISVFSMFILTPMFIKNEIDYGEISQASLCCFLFSNALGQLITEWGTSGKVSSYIERLATLTDALKVASEEPKNLSRITTLEDNRLAFENFTLQTPDYEKVIVENLSVSVPLGESLLIIGPSGRGKSSLLRAIAGLWKAGSGRLVRPPLAKMLFLPQRPYIILGTLRQQLLYPHTNEQVSDEELENILKKVNLQHLLTDKNTLDKQVNWEQILSLGEQQRLAFARLLITKPTFTILDEATSALDLANEASLYQQLQESETTFISVGHRESLFNYHRWVLELTENSHWQLSTVEDYQRKKVNNLVMMSKKSENFSSVKIETLSEVKTEHDAEIAGVSEIAEGLSHQQMQSLTDYSLSNVRSRASLGKIITAKDGFNYRYDKDPKTLKWVRI	MHNDKDLSTWQTFRRLWPTIAPFKAGLIVAGVALILNAASDTFMLSLLKPLLDDGFGKTDRSVLVWMPLVVIGLMILRGITSYVSSYCISWVSGKVVMTMRRRLFGHMMGMPVSFFDKQSTGTLLSRITYDSEQVASSSSGALITVVREGASIIGLFIMMFYYSWQLSIILIVLAPIVSIAIRVVSKRFRNISKNMQNTMGQVTTSAEQMLKGHKEVLIFGGQEVETKRFDKVSNRMRLQGMKMVSASSISDPIIQLIASLALAFVLYAASFPSVMDSLTAGTITVVFSSMIALMRPLKSLTNVNAQFQRGMAACQTLFTILDSEQEKDEGKRVIERATGDVEFRNVTFTYPGRDVPALRNINLKIPAGKTVALVGRSGSGKSTIASLITRFYDIDEGEILMDGHDLREYTLASLRNQVALVSQNVHLFNDTVANNIAYARTEQYSREQIEEAARMAYAMDFINKMDNGLDTVIGENGVLLSGGQRQRIAIARALLRDSPILILDEATSALDTESERAIQAALDELQKNRTSLVIAHRLSTIEKADEIVVVEDGVIVERGTHNDLLEHRGVYAQLHKMQFGQ	118.04	gnl|BL_ORD_ID|2185|hsp_num:0	2423			378	1620	metronidazole
BGC0000592.1|Microviridin_10 # 9429 # 9683 # -1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.396	BGC0000592.1|Microviridin_10 	9429	9683	-	Loose	550	22.3274	VEB-17	64.29	3006213	protein homolog model	n/a	n/a	monobactam; cephalosporin	antibiotic inactivation	VEB beta-lactamase	ATGGAAAAATTCAATTCTAAAGATAACTTTCTCTACCCTAAAACCAGCTACAGGGGTTTATTCACGCCACAAAATTTAGTTTTTAACGCTAATTTGCAGGAATTCGCCCTGAGAGTCTCTTTTATCGCTGGTTTACACAGTGGGGGAAAGCTTACCTCCACGGAAGCTTACGAGAAAATTAACCAGCTTTGGCAAGAGTTGAATACCAGTCAAAAATTCCTACTAGCTAATCATTTTGAGGATCACGGAGATTGA	MEKFNSKDNFLYPKTSYRGLFTPQNLVFNANLQEFALRVSFIAGLHSGGKLTSTEAYEKINQLWQELNTSQKFLLANHFEDHGD	MKIVKRILLVLLSLFFTIAYSNAQTDNLTLKIENVLKAKNARIGVAIFNSNEKDTLKINNDFHYPMQSVMKFPIALAVLSEIDKGNLSFEQKIEITPQDLLPKMWSPIKEEFPNGTTLTIEQILNYTVSESDNIGCDILLKLIGGTDSVQKFLNANHFTDISIKANEEQMHKDWNTQYQNWATPTAMNKLLIDTYNNKNQLLSKKSYDFIWKIMRETTTGSNRLKGQLPKNTIVAHKTGTSGINNGIAAATNDVGVITLPNGQLIFISVFVAESKETSEINEKIISDIAKITWDYYLNK	28.09	gnl|BL_ORD_ID|4608|hsp_num:0	5679			438	480	
